BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21276882)

  • 1. Increased bone strength is associated with improved bone microarchitecture in intact female rats treated with strontium ranelate: a finite element analysis study.
    Boyd SK; Szabo E; Ammann P
    Bone; 2011 May; 48(5):1109-16. PubMed ID: 21276882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium ranelate treatment improves trabecular and cortical intrinsic bone tissue quality, a determinant of bone strength.
    Ammann P; Badoud I; Barraud S; Dayer R; Rizzoli R
    J Bone Miner Res; 2007 Sep; 22(9):1419-25. PubMed ID: 17547534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.
    Ammann P; Shen V; Robin B; Mauras Y; Bonjour JP; Rizzoli R
    J Bone Miner Res; 2004 Dec; 19(12):2012-20. PubMed ID: 15537445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strontium ranelate: a physiological approach for an improved bone quality.
    Ammann P
    Bone; 2006 Feb; 38(2 Suppl 1):15-8. PubMed ID: 16455318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strontium ranelate enhances callus strength more than PTH 1-34 in an osteoporotic rat model of fracture healing.
    Habermann B; Kafchitsas K; Olender G; Augat P; Kurth A
    Calcif Tissue Int; 2010 Jan; 86(1):82-9. PubMed ID: 19960189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium ranelate decreases the incidence of new caudal vertebral fractures in a growing mouse model with spontaneous fractures by improving bone microarchitecture.
    Geoffroy V; Chappard D; Marty C; Libouban H; Ostertag A; Lalande A; de Vernejoul MC
    Osteoporos Int; 2011 Jan; 22(1):289-97. PubMed ID: 20204596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strontium ranelate improves implant osseointegration.
    Maïmoun L; Brennan TC; Badoud I; Dubois-Ferriere V; Rizzoli R; Ammann P
    Bone; 2010 May; 46(5):1436-41. PubMed ID: 20116464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
    Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
    J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S; Vai S
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium as therapy for osteoporosis.
    Marie PJ
    Curr Opin Pharmacol; 2005 Dec; 5(6):633-6. PubMed ID: 16183330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants.
    Bain SD; Jerome C; Shen V; Dupin-Roger I; Ammann P
    Osteoporos Int; 2009 Aug; 20(8):1417-28. PubMed ID: 19096745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Treatment with Strontium Ranelate Does Not Influence the Healing of Femoral Mid-shaft Defects in Rats.
    Vegger JB; Brüel A; Sørensen TG; Thomsen JS
    Calcif Tissue Int; 2016 Feb; 98(2):206-14. PubMed ID: 26543033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
    Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
    N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
    Marie PJ
    Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S
    J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive therapy in osteoporosis using a single drug: from ADFR to strontium ranelate.
    Manette C; Collette J; Sarlet N; Tancredi A; Zegels B; Reginster JY
    Curr Med Chem; 2006; 13(13):1585-90. PubMed ID: 16787205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preclinical evaluation of strontium ranelate in bone quality].
    Ammann P
    Rev Med Suisse Romande; 2004 Feb; 124(2):109-10. PubMed ID: 15095626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.
    Arlot ME; Jiang Y; Genant HK; Zhao J; Burt-Pichat B; Roux JP; Delmas PD; Meunier PJ
    J Bone Miner Res; 2008 Feb; 23(2):215-22. PubMed ID: 17922612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.